ArticleJournal of hepatocellular carcinoma2025
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma.
Chien-Hung Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.